{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T03:05:26Z","timestamp":1784430326893,"version":"3.55.0"},"reference-count":34,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>The population of cancer patients with second primary malignancies (SPMs) is rapidly growing. The relationship between radiotherapy and SPMs for some types of tumors is unknown or debated. In this study, we identify 24 types of first primary malignancies (FPMs) between 2004 and 2015 in the Surveillance, Epidemiology, and End Results (SEER) database. Patients in the radiotherapy group were matched to those in the no radiotherapy group with a matching ratio of 1:1. After propensity-score matching (PSM), additional competing risk regression analyses were performed to calculate the efficacy of radiotherapy to SPMs in the PSM-adjusted population. In addition, the Fine and Gray model was utilized in the primary cohorts, and stratified analyses were performed based on surgery. This study includes a total of 2,831,789 eligible patients with tumors diagnosed from 2004 to 2015 in the SEER 18 database, amongst whom 100,194 (3.5%) patients developed SPMs. We observe higher risks of SPMs associated with radiotherapy in several types of tumors in the PSM-adjusted populations (small bowel adenocarcinoma, small cell lung carcinoma, prostate adenocarcinoma, urinary bladder transitional cell carcinoma, invasive ductal breast carcinoma, invasive lobular breast carcinoma, and Hodgkin lymphoma). The results in the PSM-adjusted populations were consistent with outcomes in the multivariable competing risk models. Meanwhile, in subgroup analyses stratified by surgery, some other types of tumor (except for those with positive results in the PSM-adjusted cohorts) with radiotherapy were also associated with a higher prevalence of SPMs in the subgroups of surgical treatment (pancreatic adenocarcinoma, rectal adenocarcinoma, lung adenocarcinoma and follicular thyroid carcinoma in the surgery subgroups). The impact of radiotherapy on the incidence of secondary malignancies is distinct in different types of cancer. These findings merit further investigation and may ultimately impact treatment decision-making for tumor management.<\/jats:p>","DOI":"10.3390\/curroncol28010035","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T04:55:31Z","timestamp":1611032131000},"page":"301-316","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries"],"prefix":"10.3390","volume":"28","author":[{"given":"Wei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Plastic and Burns Surgery, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Plastic and Burns Surgery, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Plastic and Burns Surgery, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yange","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Plastic and Burns Surgery, Sichuan University, Chengdu 610041, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3857\/roj.2018.00290","article-title":"Radiation induced secondary malignancies: A review article","volume":"36","author":"Dracham","year":"2018","journal-title":"Radiat. Oncol. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.7314\/APJCP.2016.17.2.749","article-title":"Effects of Radiotherapy on the Risk of Developing Secondary Malignant Neoplasms in Hodgkin\u2019s Lymphoma Survivors","volume":"17","author":"Mikhael","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/ejh.12775","article-title":"Long-term complication in follicular lymphoma: Assessing the risk of secondary neoplasm in 242 patients treated or not with 90-yttrium-ibritumomab-tiuxetan","volume":"97","author":"Lievano","year":"2016","journal-title":"Eur. J. Haematol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1615\/CritRevOncog.2018025830","article-title":"Secondary Malignancies in the Era of High-Precision Radiation Therapy","volume":"23","author":"Eley","year":"2018","journal-title":"Crit. Rev. Oncog."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1573396313666161114233135","article-title":"Secondary Neoplasms in Children Treated for Cancer","volume":"13","author":"Kebudi","year":"2017","journal-title":"Curr. Pediatric Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00268-015-3324-x","article-title":"Secondary Cancers after Radiation Therapy for Primary Prostate or Rectal Cancer","volume":"40","author":"Lee","year":"2016","journal-title":"World J. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20170187","DOI":"10.1259\/bjr.20170187","article-title":"Assessment of radiation-induced secondary cancer risk in the Brazilian population from left-sided breast-3D-CRT using MCNPX","volume":"90","author":"Mendes","year":"2017","journal-title":"Br. J. Radiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1470-2045(11)70061-4","article-title":"Proportion of second cancers attributable to radiotherapy treatment in adults: A cohort study in the US SEER cancer registries","volume":"12","author":"Curtis","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kawada, K., Hida, K., and Sakai, Y. (2017). Advantages of transperineal approach for secondary rectal cancer following prior radiotherapy to prostate cancer\u2013video vignette. Colorectal Dis.","DOI":"10.1111\/codi.13990"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jjco\/hyw098","article-title":"Smoking effect on secondary bladder cancer after external beam radiotherapy for prostate cancer","volume":"46","author":"Shiota","year":"2016","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ijrobp.2017.10.040","article-title":"Critical Appraisal of the Risk of Secondary Cancer Induction From Breast Radiation Therapy with Volumetric Modulated Arc Therapy Relative to 3D Conformal Therapy","volume":"100","author":"Fogliata","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"13771","DOI":"10.1038\/s41598-017-14145-x","article-title":"Propensity-score-matched evaluation of the incidence of radiation pneumonitis and secondary cancer risk for breast cancer patients treated with IMRT\/VMAT","volume":"7","author":"Chao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_13","first-page":"S173","article-title":"Rapidly developed Secondary Cutaneous Squamous cell Carcinoma after Post-Surgical Radiation Therapy for Breast Cancer","volume":"99","author":"Winaikosol","year":"2016","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.radonc.2017.02.007","article-title":"Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis","volume":"123","author":"Warschkow","year":"2017","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: Evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.radonc.2018.09.017","article-title":"Volume effects of radiotherapy on the risk of second primary cancers: A systematic review of clinical and epidemiological studies","volume":"131","author":"Journy","year":"2018","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"djv366","DOI":"10.1093\/jnci\/djv366","article-title":"Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients","volume":"108","author":"Kiderlen","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1200\/JCO.2017.72.6497","article-title":"Postoperative Pelvic Radiotherapy in Patients With Endometrial Cancer May Increase the Risk for Secondary Pelvic Cancers: A Post Hoc Analysis of Results From the TME, PORTEC-1, and PORTEC-2 Trials","volume":"35","author":"Wissing","year":"2017","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_20","first-page":"CD002102","article-title":"Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma","volume":"10","author":"Abraha","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12957-018-1490-7","article-title":"Progress of preoperative and postoperative radiotherapy in gastric cancer","volume":"16","author":"Zhang","year":"2018","journal-title":"World J. Surg. Oncol."},{"key":"ref_22","first-page":"540","article-title":"Surgery after upfront radiochemotherapy for locally advanced esophageal cancer: To do or not to do?","volume":"22","author":"Crehange","year":"2018","journal-title":"Cancer Radiother. J. Soc. Fr. Radiother. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S2522","DOI":"10.21037\/jtd.2017.12.50","article-title":"Reirradiation for locoregionally recurrent non-small cell lung cancer","volume":"10","author":"Vyfhuis","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_24","first-page":"421","article-title":"Neoadjuvant chemoradiotherapy or chemotherapy? A comprehensive systematic review and meta-analysis of the options for neoadjuvant therapy for treating oesophageal cancer","volume":"51","author":"Deng","year":"2017","journal-title":"Eur. J. Cardio Thorac. Surg. Off. J. Eur. Assoc. Cardio Thorac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.radonc.2017.08.029","article-title":"Histology of non-small cell lung cancer predicts the response to stereotactic body radiotherapy","volume":"125","author":"Bernhardt","year":"2017","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/CMAR.S145713","article-title":"Radiation-induced secondary malignancies for nasopharyngeal carcinoma: A pilot study of patients treated via IMRT or VMAT","volume":"10","author":"Lee","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yamanaka, R., Abe, E., Sato, T., Hayano, A., and Takashima, Y. (2017). Secondary Intracranial Tumors Following Radiotherapy for Pituitary Adenomas: A Systematic Review. Cancers, 9.","DOI":"10.3390\/cancers9080103"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","article-title":"Secondary Breast Cancer Risk by Radiation Volume in Women with Hodgkin Lymphoma","volume":"97","author":"Conway","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2967\/jnumed.118.211359","article-title":"Radioactive Iodine Therapy for Differentiated Thyroid Cancer: Lessons from Confronting Controversial Literature on Risks for Secondary Malignancy","volume":"59","author":"Tulchinsky","year":"2018","journal-title":"J. Nucl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.rpor.2016.01.001","article-title":"Secondary malignancy following radiotherapy for thyroid eye disease","volume":"21","author":"Gillis","year":"2016","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1002\/cncr.31721","article-title":"Intensity-modulated radiotherapy improves survival and reduces treatment time in squamous cell carcinoma of the anus: A National Cancer Data Base study","volume":"124","author":"Elson","year":"2018","journal-title":"Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1002\/hed.25360","article-title":"Radiotherapy modality as a predictor of survival in hypopharyngeal cancer","volume":"40","author":"Kilic","year":"2018","journal-title":"Head Neck"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.7150\/jca.26110","article-title":"Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort","volume":"9","author":"Zhu","year":"2018","journal-title":"J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11864-017-0467-z","article-title":"Optimal Radiation Therapy for Small Cell Lung Cancer","volume":"18","author":"Gensheimer","year":"2017","journal-title":"Curr. Treat. Opt. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/35\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:08:50Z","timestamp":1760159330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/1\/35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["curroncol28010035"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28010035","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]}}}